REFERENCES
- Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol. 1996;7(10):2176–2182.
- Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int. 1997;17(4):360–364.
- Bayston R, Andrews M, Rigg K, Shelton A. Recurrent infection and catheter loss in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1999;19(6):550–555.
- Bunke CM, Brier ME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: Gram-negatives versus gram-positives in the Network 9 Peritonitis Study. Kidney Int. 1997;52(2):524–529.
- Piraino B, Bernardini J, Sorkin M. The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1986;8(6):436–440.
- Sipahioglu MH, Aybal A, Unal A, Tokgoz B, Oymak O, Utas C. Patient and technique survival and factors affecting mortality on peritoneal dialysis in Turkey: 12 years' experience in a single center. Perit Dial Int. 2008;28(3):238–245.
- Piraino B, Bernardini J, Sorkin M. Catheter infections as a factor in the transfer of continuous ambulatory peritoneal dialysis patients to hemodialysis. Am J Kidney Dis. 1989;13(5):365–369.
- Keane WF, Everett ED, Golper TA, Peritoneal dialysis-related peritonitis treatment recommendations. 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis. Perit Dial Int. 1993;13(1):14–28.
- Keane WF, Alexander SR, Bailie GR, Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int. 1996;16(6):557–573.
- Keane WF, Bailie GR, Boeschoten E, Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int. 2000;20(4):396–411.
- Piraino B, Bailie GR, Bernardini J, ; ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25(2):107–131.
- Nikolaidis P, Vas S, Lawson W, Is intraperitoneal tobramycin ototoxic in CAPD patients? Perit Dial Int. 1991;11(3):156–161.
- Gendeh BS, Said H, Gibb AG, Aziz NS, Zahir ZM. Gentamicin administration via peritoneal dialysis fluid: The risk of ototoxicity. Journal of Laryngology and Otology. 1991;105:999–1001.
- Nikolopoulos TP, Kandiloros DC, Segas JV, Auditory function in young patients with chronic renal failure. Clin Otolaryngol. 1997;22:222–225.
- Mars RL, Moles K, Pope K, Hargrove P. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis. Adv Perit Dial. 2000;16:280–284.
- van der Hulst RJ, Boeschoten EW, Nielsen FW, Struijk DG, Drechler WD, Tange RA. Otototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin. ORL J Otorhinolaryngol Related Spec. 1991;53(1):19–22.
- Gendeh BS, Said H, Gibb AG, Aziz NS, Kong N, Zahir ZM. Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis. Journal of Laryngology and Otology. 1993;107:681–685.
- Clark JG. Uses and abuses of hearing loss classification. American Speech-Language-Hearing Association, ASHA. 1981;23(7):493–500.
- Gilbert D. Aminoglycosides. In Mandell GL, Bennet JE, Dolin R ( eds.). Principles and practice of infectious diseases. 6th ed. New York: Churchill Livingstone, 2005; 328–356.
- Selimoğlu E, Kalkandelen S, Erdoğan F. Comparative vestibulutoxicity of different aminoglycosides in the Guinea pigs. Yonsei Med J. 2003;44:517–522.
- Gendeh BS, Gibb AG, Aziz NS, Kong N, Zahir ZM. Vancomycin administration in continuous ambulatory peritoneal dialysis: The risk of ototoxicity. Otolaryngol Head Neck Surg.1998;118(4):551–558.
- Wu W, Sha S, Schacht J. Recent advances in understanding aminoglycoside ototoxicity and its prevention. Audiol Neurootol. 2002;7:171–174.
- Feldman L, Efrati S, Eviatar E, Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. Kidney Int. 2007;72(3):359–363.